BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 23734265)

  • 1. TLR4 ligand/H₂O₂ enhances TGF-β1 signaling to induce metastatic potential of non-invasive breast cancer cells by activating non-Smad pathways.
    Zhou YH; Liao SJ; Li D; Luo J; Wei JJ; Yan B; Sun R; Shu Y; Wang Q; Zhang GM; Feng ZH
    PLoS One; 2013; 8(5):e65906. PubMed ID: 23734265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways.
    Martin MM; Buckenberger JA; Jiang J; Malana GE; Knoell DL; Feldman DS; Elton TS
    Am J Physiol Lung Cell Mol Physiol; 2007 Sep; 293(3):L790-9. PubMed ID: 17601799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β3 integrin promotes TGF-β1/H2O2/HOCl-mediated induction of metastatic phenotype of hepatocellular carcinoma cells by enhancing TGF-β1 signaling.
    Feng XX; Liu M; Yan W; Zhou ZZ; Xia YJ; Tu W; Li PY; Tian DA
    PLoS One; 2013; 8(11):e79857. PubMed ID: 24260309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirtuin 6 promotes transforming growth factor-β1/H2O2/HOCl-mediated enhancement of hepatocellular carcinoma cell tumorigenicity by suppressing cellular senescence.
    Feng XX; Luo J; Liu M; Yan W; Zhou ZZ; Xia YJ; Tu W; Li PY; Feng ZH; Tian DA
    Cancer Sci; 2015 May; 106(5):559-66. PubMed ID: 25683165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BIX02189 inhibits TGF-β1-induced lung cancer cell metastasis by directly targeting TGF-β type I receptor.
    Park SJ; Choi YS; Lee S; Lee YJ; Hong S; Han S; Kim BC
    Cancer Lett; 2016 Oct; 381(2):314-22. PubMed ID: 27543359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines.
    Halder SK; Cho YJ; Datta A; Anumanthan G; Ham AJ; Carbone DP; Datta PK
    Neoplasia; 2011 Oct; 13(10):912-22. PubMed ID: 22028617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells.
    Gomes LR; Terra LF; Wailemann RA; Labriola L; Sogayar MC
    BMC Cancer; 2012 Jan; 12():26. PubMed ID: 22260435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydroartemisinin inhibits the tumorigenesis and metastasis of breast cancer via downregulating CIZ1 expression associated with TGF-β1 signaling.
    Li Y; Zhou X; Liu J; Gao N; Yang R; Wang Q; Ji J; Ma L; He Q
    Life Sci; 2020 May; 248():117454. PubMed ID: 32088211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel permissive role of epidermal growth factor in transforming growth factor beta (TGF-beta) signaling and growth suppression. Mediation by stabilization of TGF-beta receptor type II.
    Song K; Krebs TL; Danielpour D
    J Biol Chem; 2006 Mar; 281(12):7765-74. PubMed ID: 16428382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DRAK2 participates in a negative feedback loop to control TGF-β/Smads signaling by binding to type I TGF-β receptor.
    Yang KM; Kim W; Bae E; Gim J; Weist BM; Jung Y; Hyun JS; Hernandez JB; Leem SH; Park T; Jeong J; Walsh CM; Kim SJ
    Cell Rep; 2012 Nov; 2(5):1286-99. PubMed ID: 23122956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells.
    Rodríguez-García A; Samsó P; Fontova P; Simon-Molas H; Manzano A; Castaño E; Rosa JL; Martinez-Outshoorn U; Ventura F; Navarro-Sabaté À; Bartrons R
    FEBS J; 2017 Oct; 284(20):3437-3454. PubMed ID: 28834297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta.
    Glinka Y; Stoilova S; Mohammed N; Prud'homme GJ
    Carcinogenesis; 2011 Apr; 32(4):613-21. PubMed ID: 21186301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth.
    Micalizzi DS; Wang CA; Farabaugh SM; Schiemann WP; Ford HL
    Cancer Res; 2010 Dec; 70(24):10371-80. PubMed ID: 21056993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways.
    Dong F; Liu T; Jin H; Wang W
    Can J Physiol Pharmacol; 2018 Jan; 96(1):1-7. PubMed ID: 28177668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of induction of airway smooth muscle hyperplasia by transforming growth factor-beta.
    Xie S; Sukkar MB; Issa R; Khorasani NM; Chung KF
    Am J Physiol Lung Cell Mol Physiol; 2007 Jul; 293(1):L245-53. PubMed ID: 17468136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor expression modulates the specificity of transforming growth factor-beta signaling pathways.
    Murakami M; Kawachi H; Ogawa K; Nishino Y; Funaba M
    Genes Cells; 2009 Apr; 14(4):469-82. PubMed ID: 19335617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
    Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
    Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salinomycin suppresses TGF-β1-induced epithelial-to-mesenchymal transition in MCF-7 human breast cancer cells.
    Zhang C; Lu Y; Li Q; Mao J; Hou Z; Yu X; Fan S; Li J; Gao T; Yan B; Wang B; Song B; Li L
    Chem Biol Interact; 2016 Mar; 248():74-81. PubMed ID: 26896736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
    Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
    Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.